Prostate cancer, affecting approximately 13% of men in the US, poses risks like erectile dysfunction post-treatment. However, a groundbreaking dual-robotic surgery performed in Texas offers new hope. Utilizing Levita Magnetics’ advanced magnetic technology, surgeons can better visualize and preserve critical nerve bundles that impact sexual and urinary functions. This approach, which combines the da Vinci robotic system with Levita's MARS platform, minimizes incisions, promotes faster recovery, and decreases postoperative complications, marking a significant advance in prostate cancer treatment.
"We have a magnetic technology that enables better retraction of the tissues and better visualization," Dr. Alberto Rodriguez-Navarro, founder and CEO of Levita Magnetics, told The Post.
"In the case of the prostate, this might result in the surgeon better seeing the nerve bundles," Rodriguez-Navarro continued. "The nerves are very important because they are related to incontinence, like urinary incontinence, and also sexual function, so preserving those nerves is critical."
"Technologies that are made by different companies are usually not made to work together ... but we can work together, which is what was cool about it," said Cadeddu.
In a robotic prostatectomy, a urologist makes five or six small incisions in the lower stomach area to access and remove the prostate gland.
Collection
[
|
...
]